Products

Earnings
API

Get in Touch

Contact Us
X (Twitter)
LinkedIn

Resources

Disclaimer: CapyFin provides financial data and AI analysis for informational purposes only and does not provide investment advice or recommendations. Real-time data and AI outputs may be inaccurate, incomplete, delayed, or contain errors or hallucinations. Investing involves risk, including loss of principal. The service is provided “as is” and we disclaim liability to the fullest extent permitted by law. See our Terms of Service and Privacy Policy.

iBio Fiscal Q4 2023 Earnings Report - CapyFin

iBio

🇺🇸 NYSE:IBIO

View Company

Overview Earnings Dividends Seasonality Metrics

Sep 27, 2023

•

Jun 30, 2023

iBio Q4 2023 Earnings Report

iBio's financial performance for fiscal year 2023 was reported, with zero revenue and a net loss of $65.0 million.

Key Takeaways

iBio reported its fiscal year 2023 results, revealing no revenue and a consolidated net loss of $65.0 million. The company's operating expenses decreased by 7% compared to the previous year. iBio held $4.3 million in cash and cash equivalents as of June 30, 2023.

iBio reported zero revenue for the fiscal year 2023.

The company's consolidated net loss for fiscal year 2023 was $65.0 million.

Operating expenses decreased by 7% compared to the previous year.

iBio held $4.3 million in cash and cash equivalents as of June 30, 2023.